Stock Notes

Fredun Pharmaceuticals

Every Finvezto stock note on Fredun Pharmaceuticals, dated and newest first. Coverage spans pharma, pharmaceuticals.

2 notes and counting
22 Sep 2026
Fredun Pharmaceuticals acquired 26 percent of pet pharmacy chain Goodman Vetcare at a 300 crore rupee valuation.
Goodman's revenue was 23.6 crore rupees in FY26, so the deal values it near 13 times sales against a target of about 100 crore rupees by FY31. The plan takes the chain from three stores to eleven.
08 Sep 2026
Fredun Pharmaceuticals acquired pet wellness brand Furlicks from USV and Wellbeing Nutrition, entering a new consumer category.
Furlicks sells oral strip formats across skin and coat, gut, joint, calming and oral care. Fredun plans 12 new products in the first phase and has not disclosed the consideration.
Finvezto Membership

Get the research behind the notes

Stock notes are the free daily layer. The membership carries the full Flexi-Wealth system: an ETF core portfolio with monthly rebalancing signals, fifteen quality-momentum stocks with exact weightages every month, options income and hedging recommendations, and the institutional data toolkit. One flat membership covers everything.

Become a Member Read free sample research →

Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630. Stock notes are market commentary for general information and education. They are not investment advice, not a recommendation to buy or sell, and do not account for any individual's financial situation. Investment in securities is subject to market risks. Please read all related documents carefully before investing. Past performance is not a guarantee of future results.